Member Info for Markshares

Taken a small position here in prep for whatever news comes by the end of this month

Earache, you are getting acacia mixed up with invesco

I didn't.

At some point Cathal will have to address the IIs question, he doesn't have to justify Invesco selling in particular, but he said he wanted to stop the share price spiking as institutions would sell, well they're selling anyway. He said that the placing instructions were just "trimming", not selling out but for all intents and purposes, that was effectively a lie, and he has failed to get any new long term institutional investors onboard.

For me it is the only really doubt with ORPH when everything looks and reads so amazingly otherwise. IIs are no idiots so why is our enthusiasm not being shared?

Really beginning look like the government might be financing stage 3 of a repurposed flu-v vaccine. ORPH has said from the off that we believe it could be repurposed in that way.

Can imagine convos started when CF signed the challenge study contracts ..."by the way, while you guys are you, what do you think of this little thing?..."

I mentioned biondvax buying out flu v in a few forums , including those in Us Biondvax chat groups and was pretty much universally poo pooed, but I think it's probably the most likely deal for flu v out of any of them

Why 4 years? I thought CF always talked about it being much shorter than that

I assume this is the existing £40m being signed off(?), not a NEW £46m?!

Amazing news and a £6m discrepancy in our favour?!

Yes, will be very interesting to see the next financials. I assume it will show a small loss for last year but highlight a move to profit from Q4 and beyond

Yes SGS facility would make sense and would tie in perfectly with CFs "bemused" statement, as they are a competitor

Why 10% or are you just plucking a bad number out of thin air? Flu v and AGs v are by far their two most promising and developed assets

Probably another coffee shop or maybe a bakery

I think there is huge potential for licensing of challenge studies to other countries and training too

I think you may have missed the point there, Peter!

Greend, I make the same assumption, I'd guess they would be interested in the data either way but no doubt the potential for Covid data is what would interest them the most and the price could be 2-3x it, with that included. Makes sense for any deal to hold out until they know what is included exactly. They could have two deals in principle in place already, dependant on MHRA approval or not.

Certainly looks like CF is good to his word on SPAC listing this month. All evidence pointing towards that and very strong evidence it is too. I can imagine Immutex being well recieved over in America too, hopefully there will be a couple of write ups on its potential... maybe one or two paid by ORPH.

I've bought some more at 24.6ish, stock is NT to buy on smaller volumes so A tick up from here pretty much guaranteed and you have to feel this news is imminent

Feza, your questions are shocking, why did you buy here? Please don't buy and sell because people online tell you to

Seems to only ever rise directly before an RNS and I believe orph is leaky in that regard

What are you talking about bronxville, an hour ago you are claiming you post your questions here solely for Cathal to read, in a forum he would never in a million years reply on, then your next post you are saying its pointless contacting him directly as he can't give sensitive information out.

Which is it?

If you are asking for sensitive information, you won't get it here, and if you are just looking to ask rhetorical questions to Cathal or highlight your dissatisfaction at anything, then his email is obviously a better place to do it. No one uses a bulletin board as a means of communication to speak to leaders of companies, so you'll need to find a new rhetoric if you expect people who to think you aren't two-faced. When you talk a lot of sh*t all day, you do have to stay consistent in your lies, Bronxville.

Seems its creeping back up! Have seen shares days like this end green once the dust settles and sorely tempted to click that buy button now